{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["SARS-CoV-2", "density functional theory", "heterocyclic inhibitors", "molecular docking", "molecular dynamics"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "33200681", "DateCompleted": {"Year": "2022", "Month": "04", "Day": "01"}, "DateRevised": {"Year": "2023", "Month": "09", "Day": "17"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "11", "Day": "17"}], "Language": ["eng"], "ELocationID": ["10.1080/07391102.2020.1845800"], "Journal": {"ISSN": "1538-0254", "JournalIssue": {"Volume": "40", "Issue": "7", "PubDate": {"Year": "2022", "Month": "Apr"}}, "Title": "Journal of biomolecular structure & dynamics", "ISOAbbreviation": "J Biomol Struct Dyn"}, "ArticleTitle": "Determination of potential inhibitors based on isatin derivatives against SARS-CoV-2 main protease (m<sup>pro</sup>): a molecular docking, molecular dynamics and structure-activity relationship studies.", "Pagination": {"StartPage": "3110", "EndPage": "3128", "MedlinePgn": "3110-3128"}, "Abstract": {"AbstractText": ["SARS-COV-2, the novel coronavirus and root of global pandemic COVID-19 caused a severe health threat throughout the world. Lack of specific treatments raised an effort to find potential inhibitors for the viral proteins. The recently invented crystal structure of SARS-CoV-2 main protease (M<sup>pro</sup>) and its key role in viral replication; non-resemblance to any human protease makes it a perfect target for inhibitor research. This article reports a computer-aided drug design (CADD) approach for the screening of 118 compounds with 16 distinct heterocyclic moieties in comparison with 5 natural products and 7 repurposed drugs. Molecular docking analysis against M<sup>pro</sup> protein were performed finding isatin linked with a oxidiazoles (<b>A2 and A4</b>) derivatives to have the best docking scores of -11.22\u2009kcal/mol and -11.15\u2009kcal/mol respectively. Structure-activity relationship studies showed a good comparison with a known active M<sup>pro</sup> inhibitor and repurposed drug ebselen with an IC<sub>50</sub> value of -0.67\u2009\u03bcM. Molecular Dynamics (MD) simulations for 50\u2009ns were performed for <b>A2</b> and <b>A4</b> supporting the stability of the two compounds within the binding pocket, largely at the S1, S2 and S4 domains with high binding energy suggesting their suitability as potential inhibitors of M<sup>pro</sup> for SARS-CoV-2."]}, "AuthorList": [{"Identifier": ["0000-0002-6433-2691"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute for Drug Research, The Hebrew University, Jerusalem, Israel."}], "LastName": "Badavath", "ForeName": "Vishnu Nayak", "Initials": "VN"}, {"Identifier": ["0000-0003-4997-9486"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biotechnology Division, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow, India."}], "LastName": "Kumar", "ForeName": "Akhil", "Initials": "A"}, {"Identifier": ["0000-0002-1926-7720"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Chemical and Bioprocess Engineering, University College Dublin, Dublin, Ireland."}], "LastName": "Samanta", "ForeName": "Pralok K", "Initials": "PK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, Ranchi, India."}], "LastName": "Maji", "ForeName": "Siddhartha", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, Institute of Science, GITAM (Deemed to be University), Visakhapatnam, India."}], "LastName": "Das", "ForeName": "Anik", "Initials": "A"}, {"Identifier": ["0000-0002-9374-2489"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute for Drug Research, The Hebrew University, Jerusalem, Israel."}], "LastName": "Blum", "ForeName": "Galia", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, Institute of Science, GITAM (Deemed to be University), Visakhapatnam, India."}], "LastName": "Jha", "ForeName": "Anjali", "Initials": "A"}, {"Identifier": ["0000-0002-1336-5995"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, Institute of Science, GITAM (Deemed to be University), Visakhapatnam, India."}], "LastName": "Sen", "ForeName": "Anik", "Initials": "A"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "J Biomol Struct Dyn", "NlmUniqueID": "8404176", "ISSNLinking": "0739-1102"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Protease Inhibitors"}, {"RegistryNumber": "82X95S7M06", "NameOfSubstance": "Isatin"}, {"RegistryNumber": "EC 3.4.22.-", "NameOfSubstance": "3C-like proteinase, SARS-CoV-2"}, {"RegistryNumber": "EC 3.4.22.28", "NameOfSubstance": "Coronavirus 3C Proteases"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": [], "DescriptorName": "Coronavirus 3C Proteases"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Isatin"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Dynamics Simulation"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Protease Inhibitors"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}], "CoiStatement": "There are no conflicts to declare."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Afifi, T. H., Okasha, R. M., Ahmed, H. E. A., Ila\u0161, J., Saleh, T., & Abd-El-Aziz, A. S. (2017). Structure-activity relationships and molecular docking studies of chromene and chromene based azo chromophores: A novel series of potent antimicrobial and anticancer agents. EXCLI Journal, 16, 868\u2013902. 10.17179/excli2017-356", "ArticleIdList": ["10.17179/excli2017-356", "PMC5547389", "28828001"]}, {"Citation": "Agarwal, M., Singh, V., Sharma, S. K., Sharma, P., Ansari, M. Y., Jadav, S. S., Yasmin, S., Sreenivasulu, R., Hassan, M. Z., Saini, V., & Ahsan, M. J. (2016). Design and synthesis of new 2,5-disubstituted-1,3,4-oxadiazole analogues as anticancer agents. Medicinal Chemistry Research, 25(10), 2289\u20132303."}, {"Citation": "Anand, P. S., Sethukumar, A., Kumar, C. U., Krishnasamy, K., Senthan, S., Manikandan, G., & Prakasam, B. A. (2019). Synthesis, spectroscopic investigation, computational, stereochemical and biological studies of 1, 3-dimethyl-2, 6-diphenylpiperidin-4-one N (4\u2032)-cyclohexylsemicarbazone: Crystal structure and Hirshfeld surface analysis. Chemical Data Collections, 21, 100216."}, {"Citation": "Badavath, V. N., Baysal, I., Ucar, G., Sinha, B. N., & Jayaprakash, V. (2016. a). Monoamine oxidase inhibitory activity of novel pyrazoline analogues: Curcumin based design and synthesis. ACS Medicinal Chemistry Letters, 7(1), 56\u201361. 10.1021/acsmedchemlett.5b00326", "ArticleIdList": ["10.1021/acsmedchemlett.5b00326", "PMC4716609", "26819666"]}, {"Citation": "Badavath, V. N., Baysal, I., U\u00e7ar, G., Mondal, S. K., Sinha, B. N., & Jayaprakash, V. (2016. b). Monoamine oxidase inhibitory activity of ferulic acid amides: Curcumin-based design and synthesis. Archiv Der Pharmazie, 349(1), 9\u201319. 10.1002/ardp.201500317", "ArticleIdList": ["10.1002/ardp.201500317", "26592858"]}, {"Citation": "Badavath, V. N., Ucar, G., Sinha, B. N., Mondal, S. K., & Jayaprakash, V. (2016. c). Monoamine oxidase inhibitory activity of novel pyrazoline analogues: Curcumin based design and synthesis-II. ChemistrySelect, 1(18), 5879\u20135884.", "ArticleIdList": ["PMC4716609", "26819666"]}, {"Citation": "Badavath, V. N., Baysal, I., Ucar, G., Sinha, B. N., & Jayaprakash, V. (2015). Monoamine oxidase inhibitory activity of novel pyrazoline analogues: Curcumin based design and synthesis. ACS Medicinal Chemistry Letters.", "ArticleIdList": ["PMC4716609", "26819666"]}, {"Citation": "Badavath, V. N., Nath, C., Ganta, N. M., Ucar, G., Sinha, B. N., & Jayaprakash, V. (2017). Design, synthesis and MAO inhibitory activity of 2-(arylmethylidene)-2,3-dihydro-1-benzofuran-3-one derivatives. Chinese Chemical Letters, 28(7), 1528\u20131532. 10.1016/j.cclet.2017.02.009", "ArticleIdList": ["10.1016/j.cclet.2017.02.009"]}, {"Citation": "Bauer, D. J., & Sadler, P. W. (1960). The structure-activity relationships of the antiviral chemotherapeutic activity of isatin beta-thiosemicarbazone. British Journal of Pharmacology and Chemotherapy, 15(1), 101\u2013110. 10.1111/j.1476-5381.1960.tb01216.x", "ArticleIdList": ["10.1111/j.1476-5381.1960.tb01216.x", "PMC1481969", "13797622"]}, {"Citation": "Becke, A. D. (1993). Density-functional thermochemistry. III. The role of exact exchange. Journal of Chemical Physics, 98(7), 5648\u20135652."}, {"Citation": "Beedie, S. L., Peer, C. J., Pisle, S., Gardner, E. R., Mahony, C., Barnett, S., Ambrozak, A., G\u00fctschow, M., Chau, C. H., Vargesson, N., & Figg, W. D. (2015). Anticancer properties of a novel class of tetrafluorinated thalidomide analogues. Molecular Cancer Therapeutics, 14(10), 2228\u20132237. 10.1158/1535-7163.MCT-15-0320", "ArticleIdList": ["10.1158/1535-7163.MCT-15-0320", "PMC4596783", "26269604"]}, {"Citation": "Ben-Zvi, I., Kivity, S., Langevitz, P., & Shoenfeld, Y. (2012). Hydroxychloroquine: From malaria to autoimmunity. Clinical Reviews in Allergy & Immunology, 42(2), 145\u2013153. 10.1007/s12016-010-8243-x", "ArticleIdList": ["10.1007/s12016-010-8243-x", "PMC7091063", "21221847"]}, {"Citation": "Bhatt, P., Kumar, M., & Jha, A. (2018). Design, synthesis and anticancer evaluation of oxa/thiadiazolylhydrazones of barbituric and thiobarbituric acid: A collective in\u00a0vitro and in silico approach. ChemistrySelect, 3(25), 7060\u20137065."}, {"Citation": "Bhatt, P., Sen, A., & Jha, A. (2020). Design and ultrasound assisted synthesis of novel 1, 3, 4\u2010oxadiazole drugs for anti\u2010cancer activity. ChemistrySelect, 5(11), 3347\u20133354. 10.1002/slct.201904412", "ArticleIdList": ["10.1002/slct.201904412"]}, {"Citation": "Bhattacharjee, M. K. (2016). Chemistry of antibiotics and related drugs (Vol. 219). Springer."}, {"Citation": "Blair, J. A., Rauh, D., Kung, C., Yun, C.-H., Fan, Q.-W., Rode, H., Zhang, C., Eck, M. J., Weiss, W. A., & Shokat, K. M. (2007). Structure-guided development of affinity probes for tyrosine kinases using chemical genetics. Nature Chemical Biology, 3(4), 229\u2013238. 10.1038/nchembio866", "ArticleIdList": ["10.1038/nchembio866", "17334377"]}, {"Citation": "Burger, A. (1979). Burger\u2019s medicinal chemistry. Wiley."}, {"Citation": "Bz\u00f3wka, M., Mitusi\u0144ska, K., Raczy\u0144ska, A., Samol, A., Tuszy\u0144ski, J. A., & G\u00f3ra, A. (2020). Structural and evolutionary analysis indicate that the SARS-CoV-2 Mpro is a challenging target for small-molecule inhibitor design. International Journal of Molecular Sciences, 21(9), 3099. 10.3390/ijms21093099", "ArticleIdList": ["10.3390/ijms21093099", "PMC7247150", "32353978"]}, {"Citation": "Chen, L.-R., Wang, Y.-C., Lin, Y. W., Chou, S.-Y., Chen, S.-F., Liu, L. T., Wu, Y.-T., Kuo, C.-J., Chen, T. S.-S., & Juang, S.-H. (2005). Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors. Bioorganic & Medicinal Chemistry Letters, 15(12), 3058\u20133062. 10.1016/j.bmcl.2005.04.027", "ArticleIdList": ["10.1016/j.bmcl.2005.04.027", "PMC7119080", "15896959"]}, {"Citation": "Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., Xia, J., Yu, T., Zhang, X., & Zhang, L. (2020. a). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. The Lancet, 395(10223), 507\u2013513.", "ArticleIdList": ["PMC7135076", "32007143"]}, {"Citation": "Chen, Y. W., Yiu, C.-P., & Wong, K.-Y. (2020. b). Prediction of the 2019-nCoV 3C-like protease (3CLpro) structure: Virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates. F1000Res, 9, 129. 10.12688/f1000research.22457.2.", "ArticleIdList": ["10.12688/f1000research.22457.2", "PMC7062204", "32194944"]}, {"Citation": "Chen, Z.-M., Fu, J.-F., Shu, Q., Chen, Y.-H., Hua, C.-Z., Li, F.-B., Lin, R., Tang, L.-F., Wang, T.-L., Wang, W., Wang, Y.-S., Xu, W.-Z., Yang, Z.-H., Ye, S., Yuan, T.-M., Zhang, C.-M., & Zhang, Y.-Y. (2020. c). Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. World Journal of Pediatrics: WJP, 16(3), 240\u2013247.", "ArticleIdList": ["PMC7091166", "32026148"]}, {"Citation": "Cortegiani, A., Ingoglia, G., Ippolito, M., Giarratano, A., & Einav, S. (2020). A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. Journal of Critical Care, 57, 279\u2013283. 10.1016/j.jcrc.2020.03.005", "ArticleIdList": ["10.1016/j.jcrc.2020.03.005", "PMC7270792", "32173110"]}, {"Citation": "Dai, W., Zhang, B., Jiang, X.-M., Su, H., Li, J., Zhao, Y., Xie, X., Jin, Z., Peng, J., Liu, F., Li, C., Li, Y., Bai, F., Wang, H., Cheng, X., Cen, X., Hu, S., Yang, X., Wang, J., \u2026 Liu, H. (2020). Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease. Science (New York, N.Y.), 368(6497), 1331\u20131335. 10.1126/science.abb4489", "ArticleIdList": ["10.1126/science.abb4489", "PMC7179937", "32321856"]}, {"Citation": "Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7, 42717. 10.1038/srep42717", "ArticleIdList": ["10.1038/srep42717", "PMC5335600", "28256516"]}, {"Citation": "Darden, T., York, D., & Pedersen, L. (1993). Particle mesh Ewald: An N\u22c5 log (N) method for Ewald sums in large systems. The Journal of Chemical Physics, 98(12), 10089\u201310092. 10.1063/1.464397", "ArticleIdList": ["10.1063/1.464397"]}, {"Citation": "De Clercq, E. (2006). Potential antivirals and antiviral strategies against SARS coronavirus infections. Expert Review of Anti-Infective Therapy, 4(2), 291\u2013302. 10.1586/14787210.4.2.291", "ArticleIdList": ["10.1586/14787210.4.2.291", "PMC7105749", "16597209"]}, {"Citation": "Dong, L., Song, B., Wu, J., Wu, Z., Zhu, Y., Chen, X., & Hu, D. (2016). Synthesis and antiviral activity of novel thioether derivatives containing 1, 3, 4-oxadiazole/thiadiazole and emodin moieties. Phosphorus, Sulfur, and Silicon and the Related Elements, 191(6), 904\u2013907. 10.1080/10426507.2015.1114944", "ArticleIdList": ["10.1080/10426507.2015.1114944"]}, {"Citation": "Einarsson, K. (1994). Effect of ursodeoxycholic acid on hepatic cholesterol metabolism. Scandinavian Journal of Gastroenterology, 29(sup 204), 19\u201323. 10.3109/00365529409103620", "ArticleIdList": ["10.3109/00365529409103620", "7824873"]}, {"Citation": "Enogieru, A. B., Haylett, W., Hiss, D. C., Bardien, S., & Ekpo, O. E. (2018). Rutin as a potent antioxidant: Implications for neurodegenerative disorders. Oxidative Medicine and Cellular Longevity, 2018, 6241017.", "ArticleIdList": ["PMC6040293", "30050657"]}, {"Citation": "Essmann, U., Perera, L., Berkowitz, M. L., Darden, T., Lee, H., & Pedersen, L. G. (1995). A smooth particle mesh Ewald method. The Journal of Chemical Physics, 103(19), 8577\u20138593. 10.1063/1.470117", "ArticleIdList": ["10.1063/1.470117"]}, {"Citation": "Fan, H.-H., Wang, L.-Q., Liu, W.-L., An, X.-P., Liu, Z.-D., He, X.-Q., Song, L.-H., & Tong, Y.-G. (2020). Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model. Chinese Medical Journal.", "ArticleIdList": ["PMC7147283", "32149769"]}, {"Citation": "Fischer, A., Sellner, M., Neranjan, S., Smie\u0161ko, M., & Lill, M. A. (2020). Potential inhibitors for novel coronavirus protease identified by virtual screening of 606 million compounds. International Journal of Molecular Sciences, 21(10), 3626. 10.3390/ijms21103626", "ArticleIdList": ["10.3390/ijms21103626", "PMC7279339", "32455534"]}, {"Citation": "Fischmann, T. O., Hruza, A., Duca, J. S., Ramanathan, L., Mayhood, T., Windsor, W. T., Le, H. V., Guzi, T. J., Dwyer, M. P., Paruch, K., Doll, R. J., Lees, E., Parry, D., Seghezzi, W., & Madison, V. (2008). Structure-guided discovery of cyclin-dependent kinase inhibitors. Biopolymers, 89(5), 372\u2013379. 10.1002/bip.20868", "ArticleIdList": ["10.1002/bip.20868", "17937404"]}, {"Citation": "Forli, W., Halliday, S., Belew, R., & Olson, A. J. (2012). AutoDock (Version 4.2). Citeseer."}, {"Citation": "Gangireddy, M. R., Mantipally, M., Gundla, R., Badavath, V. N., Paidikondala, K., & Yamala, A. (2019). Design and synthesis of piperazine\u2010linked imidazo [1, 2\u2010a] pyridine derivatives as potent anticancer agents. ChemistrySelect, 4(46), 13622\u201313629."}, {"Citation": "Gautret, P., Lagier, J.-C., Parola, P., Hoang, V. T., Meddeb, L., Mailhe, M., Doudier, B., Courjon, J., Giordanengo, V., Vieira, V. E., Tissot Dupont, H., Honor\u00e9, S., Colson, P., Chabri\u00e8re, E., La Scola, B., Rolain, J.-M., Brouqui, P., & Raoult, D. (2020). Hydroxychloroquine and azithromycin as a treatment of COVID-19: Results of an open-label non-randomized clinical trial. International Journal of Antimicrobial Agents, 56(1), 105949.", "ArticleIdList": ["PMC7102549", "32205204"]}, {"Citation": "Gerova, M. S., Stateva, S. R., Radonova, E. M., Kalenderska, R. B., Rusew, R. I., Nikolova, R. P., Chanev, C. D., Shivachev, B. L., Apostolova, M. D., & Petrov, O. I. (2016). Combretastatin A-4 analogues with benzoxazolone scaffold: Synthesis, structure and biological activity. European Journal of Medicinal Chemistry, 120, 121\u2013133. 10.1016/j.ejmech.2016.05.012", "ArticleIdList": ["10.1016/j.ejmech.2016.05.012", "27187864"]}, {"Citation": "Ghosh, A. K., Osswald, H. L., & Prato, G. (2016). Recent progress in the development of HIV-1 protease inhibitors for the treatment of HIV/AIDS. Journal of Medicinal Chemistry, 59(11), 5172\u20135208. 10.1021/acs.jmedchem.5b01697", "ArticleIdList": ["10.1021/acs.jmedchem.5b01697", "PMC5598487", "26799988"]}, {"Citation": "Gorbalenya, A. E., Baker, S. C., Baric, R., Groot, R. J., de Drosten, C., Gulyaeva, A. A., Haagmans, B. L., Lauber, C., Leontovich, A. M., Neuman, B. W., & Penzar, D. (2020). Severe acute respiratory syndrome-related coronavirus: The species and its viruses\u2013a statement of the Coronavirus Study Group."}, {"Citation": "Hall Jr, D. C., & Ji, H.-F. (2020). A search for medications to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2 spike glycoprotein and 3CL protease. Travel Medicine and Infectious Disease, 35, 101646. 10.1016/j.tmaid.2020.101646", "ArticleIdList": ["10.1016/j.tmaid.2020.101646", "PMC7152904", "32294562"]}, {"Citation": "Hess, B., Bekker, H., Berendsen, H. J. C., & Fraaije, J. G. E. M. (1997). LINCS: A linear constraint solver for molecular simulations. Journal of Computational Chemistry, 18(12), 1463\u20131472. 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H", "ArticleIdList": ["10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H"]}, {"Citation": "Hess, B., Kutzner, C., Van Der Spoel, D., & Lindahl, E. (2008). GROMACS 4:\u2009Algorithms for highly efficient, load-balanced, and scalable molecular simulation. Journal of Chemical Theory and Computation, 4(3), 435\u2013447. 10.1021/ct700301q", "ArticleIdList": ["10.1021/ct700301q", "26620784"]}, {"Citation": "Huey, R., Morris, G. M., Olson, A. J., & Goodsell, D. S. (2007). A semiempirical free energy force field with charge-based desolvation. Journal of Computational Chemistry, 28(6), 1145\u20131152. 10.1002/jcc.20634", "ArticleIdList": ["10.1002/jcc.20634", "17274016"]}, {"Citation": "Huynh, T., Wang, H., & Luan, B. (2020). In silico exploration of the molecular mechanism of clinically oriented drugs for possibly inhibiting SARS-CoV-2's main protease. The Journal of Physical Chemistry Letters, 11(11), 4413\u20134420. 10.1021/acs.jpclett.0c00994", "ArticleIdList": ["10.1021/acs.jpclett.0c00994", "32406687"]}, {"Citation": "Ivanova, Y., Momekov, G., Petrov, O., Karaivanova, M., & Kalcheva, V. (2007). Cytotoxic Mannich bases of 6-(3-aryl-2-propenoyl)-2(3H)-benzoxazolones. European Journal of Medicinal Chemistry, 42(11\u201312), 1382\u20131387. 10.1016/j.ejmech.2007.02.019", "ArticleIdList": ["10.1016/j.ejmech.2007.02.019", "17459529"]}, {"Citation": "Jha, A., & Ramarao, T. A. (2018). Expeditious microwave-assisted synthesis and bio-evaluation of novel bis (trifluoromethyl) phenyl-triazole-pyridine hybrid analogues by the click chemistry approach. Research on Chemical Intermediates, 44(1), 585\u2013599. 10.1007/s11164-017-3121-2", "ArticleIdList": ["10.1007/s11164-017-3121-2"]}, {"Citation": "Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., & Peng, C. (2020. a). Structure of Mpro from COVID-19 virus and discovery of its inhibitors. Nature.", "ArticleIdList": ["32272481"]}, {"Citation": "Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., Peng, C., Duan, Y., Yu, J., Wang, L., Yang, K., Liu, F., Jiang, R., Yang, X., You, T., Liu, X., \u2026 Yang, H. (2020. b). Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature, 582(7811), 289\u2013293. 10.1038/s41586-020-2223-y", "ArticleIdList": ["10.1038/s41586-020-2223-y", "32272481"]}, {"Citation": "Keogh-Brown, M. R., & Smith, R. D. (2008). The economic impact of SARS: How does the reality match the predictions? Health Policy (Amsterdam, Netherlands), 88(1), 110\u2013120. 10.1016/j.healthpol.2008.03.003", "ArticleIdList": ["10.1016/j.healthpol.2008.03.003", "PMC7114672", "18436332"]}, {"Citation": "Kharb, R., Shahar Yar, M., & Chander Sharma, P. (2011). Recent advances and future perspectives of triazole analogs as promising antiviral agents. Mini Reviews in Medicinal Chemistry, 11(1), 84\u201396. 10.2174/138955711793564051", "ArticleIdList": ["10.2174/138955711793564051", "21034403"]}, {"Citation": "Kok, S. H. L., Gambari, R., Chui, C. H., Yuen, M. C. W., Lin, E., Wong, R. S. M., Lau, F. Y., Cheng, G. Y. M., Lam, W. S., Chan, S. H., Lam, K. H., Cheng, C. H., Lai, P. B. S., Yu, M. W. Y., Cheung, F., Tang, J. C. O., & Chan, A. S. C. (2008). Synthesis and anti-cancer activity of benzothiazole containing phthalimide on human carcinoma cell lines. Bioorganic & Medicinal Chemistry, 16(7), 3626\u20133631. 10.1016/j.bmc.2008.02.005", "ArticleIdList": ["10.1016/j.bmc.2008.02.005", "18295491"]}, {"Citation": "Kumari, R., Kumar, R., Consortium, O. S. D. D., & Lynn, A. (2014). g_mmpbsa-A GROMACS tool for high-throughput MM-PBSA calculations. Journal of Chemical Information and Modeling, 54(7), 1951\u20131962. 10.1021/ci500020m", "ArticleIdList": ["10.1021/ci500020m", "24850022"]}, {"Citation": "Lakshmithendral, K., Saravanan, K., Elancheran, R., Archana, K., Manikandan, N., Arjun, H. A., Ramanathan, M., Lokanath, N. K., & Kabilan, S. (2019). Design, synthesis and biological evaluation of 2-(phenoxymethyl)-5-phenyl-1,3,4-oxadiazole derivatives as anti-breast cancer agents. European Journal of Medicinal Chemistry, 168, 1\u201310. 10.1016/j.ejmech.2019.02.033", "ArticleIdList": ["10.1016/j.ejmech.2019.02.033", "30798049"]}, {"Citation": "Lane, M. E., Yu, B., Rice, A., Lipson, K. E., Liang, C., Sun, L., Tang, C., McMahon, G., Pestell, R. G., & Wadler, S. (2001). A Novel cdk2-selective inhibitor, SU9516, induces apoptosis in colon carcinoma cells. Cancer Research, 61(16), 6170\u20136177.", "ArticleIdList": ["11507069"]}, {"Citation": "Lee, C., Yang, W., & Parr, R. G. (1988). Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Physical Review B, 37(2), 785\u2013789. 10.1103/PhysRevB.37.785", "ArticleIdList": ["10.1103/PhysRevB.37.785", "9944570"]}, {"Citation": "Li, Y., Zhang, J., Wang, N., Li, H., Shi, Y., Guo, G., Liu, K., Zeng, H., & Zou, Q. (2020). Therapeutic drugs targeting 2019-nCoV main protease by high-throughput screening. BioRxiv."}, {"Citation": "Li, Z., Zhan, P., & Liu, X. (2011). 1,3,4-oxadiazole: A privileged structure in antiviral agents. Mini Reviews in Medicinal Chemistry, 11(13), 1130\u20131142. 10.2174/138955711797655407", "ArticleIdList": ["10.2174/138955711797655407", "22353222"]}, {"Citation": "Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 23(1\u20133), 3\u201325. 10.1016/S0169-409X(96)00423-1", "ArticleIdList": ["10.1016/S0169-409X(96)00423-1", "11259830"]}, {"Citation": "Liu, K., Tang, M., Liu, Q., Han, X., Jin, H., Zhu, H., Li, Y., He, L., Ji, H., & Zhou, B. (2020). Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in\u00a0vitro. Cell Discovery, 6(1), 1\u20134. 10.1038/s41421-019-0132-8", "ArticleIdList": ["10.1038/s41421-019-0132-8", "PMC7078228", "32194981"]}, {"Citation": "Liu, X., & Wang, X.-J. (2020). Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines. Journal of Genetics and Genomics\u2009=\u2009Yi Chuan Xue Bao, 47(2), 119\u2013121. 10.1016/j.jgg.2020.02.001", "ArticleIdList": ["10.1016/j.jgg.2020.02.001", "PMC7128649", "32173287"]}, {"Citation": "Mallikarjuna, N., Vasudharani, D., & Ambrish, S. (2020). Screening of chloroquine, hydroxychloroquine and its derivatives for their binding affinity to multiple SARS-CoV-2 protein drug targets. Journal of Biomolecular Structure and Dynamics, 1\u201313.", "ArticleIdList": ["PMC7332874", "32579059"]}, {"Citation": "Mark, P., & Nilsson, L. (2001). Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K. The Journal of Physical Chemistry A, 105(43), 9954\u20139960. 10.1021/jp003020w", "ArticleIdList": ["10.1021/jp003020w"]}, {"Citation": "Martin, F., & Zipse, H. (2005). Charge distribution in the water molecule-a comparison of methods. Journal of Computational Chemistry, 26(1), 97\u2013105. 10.1002/jcc.20157", "ArticleIdList": ["10.1002/jcc.20157", "15547940"]}, {"Citation": "Mendel, D. B., Laird, A. D., Xin, X., Louie, S. G., Christensen, J. G., Li, G., Schreck, R. E., Abrams, T. J., Ngai, T. J., Lee, L. B., Murray, L. J., Carver, J., Chan, E., Moss, K. G., Haznedar, J. O., Sukbuntherng, J., Blake, R. A., Sun, L., Tang, C., \u2026 Cherrington, J. M. (2003). In vivo antitumor activity of SU11248 antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 9(1), 327\u2013337.", "ArticleIdList": ["12538485"]}, {"Citation": "Mittal, L., Kumari, A., Srivastava, M., Singh, M., & Asthana, S. (2020). Identification of potential molecules against COVID-19 main protease through structure-guided virtual screening approach. Journal of Biomolecular Structure and Dynamics, 1\u201326.", "ArticleIdList": ["PMC7256355", "32396769"]}, {"Citation": "Munusamy, S., Badavath, V. N., Maji, S., Sekar, M., & Shabbir, M. (2019). Novel halogenated pyrido [2, 3-a] carbazole with enhanced aromaticity as potent anticancer and antioxidant: Rationale design and microwave assisted synthesis. New Journal of Chemistry, 43(44), 17231\u201317240."}, {"Citation": "Nath, C., Badavath, V. N., Thakur, A., Ucar, G., Acevedo, O., Mohd Siddique, M. U., & Jayaprakash, V. (2018). Curcumin-based pyrazoline analogues as selective inhibitors of human monoamine oxidase A. MedChemComm, 9(7), 1164\u20131171. 10.1039/C8MD00196K", "ArticleIdList": ["10.1039/C8MD00196K", "PMC6071705", "30109004"]}, {"Citation": "Nayak, B. V., Ciftci-Yabanoglu, S., Bhakat, S., Timiri, A. K., Sinha, B. N., Ucar, G., Soliman, M. E. S., & Jayaprakash, V. (2015). Monoamine oxidase inhibitory activity of 2-aryl-4H-chromen-4-ones. Bioorganic Chemistry, 58, 72\u201380. 10.1016/j.bioorg.2014.11.008", "ArticleIdList": ["10.1016/j.bioorg.2014.11.008", "25506816"]}, {"Citation": "Ogliaro, F., Bearpark, M. J., Heyd, J. J., Brothers, E. N., Kudin, K. N., Staroverov, V. N., \u2026 Raghavachari, K. (2016). Gaussian 16, Revision A. 03. Gaussian, Inc."}, {"Citation": "Pandeya, S. N., Sriram, D., Nath, G., & De Clercq, E. (2000). Synthesis, antibacterial, antifungal and anti-HIV activities of norfloxacin Mannich bases. European Journal of Medicinal Chemistry, 35(2), 249\u2013255. 10.1016/s0223-5234(00)00125-2", "ArticleIdList": ["10.1016/s0223-5234(00)00125-2", "10758286"]}, {"Citation": "Pauwels, R., Balzarini, J., Baba, M., Snoeck, R., Schols, D., Herdewijn, P., Desmyter, J., & De Clercq, E. (1988). Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. Journal of Virological Methods, 20(4), 309\u2013321.", "ArticleIdList": ["2460479"]}, {"Citation": "Pessoa, C., Ferreira, P. M. P., Lotufo, L. V. C., de Moraes, M. O., Cavalcanti, S. M. T., Co\u00ealho, L. C. D., Hernandes, M. Z., Leite, A. C. L., De Simone, C. A., Costa, V. M. A., & Souza, V. M. O. (2010). Discovery of phthalimides as immunomodulatory and antitumor drug prototypes. ChemMedChem, 5(4), 523\u2013528. 10.1002/cmdc.200900525", "ArticleIdList": ["10.1002/cmdc.200900525", "20112332"]}, {"Citation": "Pillaiyar, T., Manickam, M., Namasivayam, V., Hayashi, Y., & Jung, S.-H. (2016). An overview of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 3CL protease inhibitors: Peptidomimetics and small molecule chemotherapy. Journal of Medicinal Chemistry, 59(14), 6595\u20136628. 10.1021/acs.jmedchem.5b01461", "ArticleIdList": ["10.1021/acs.jmedchem.5b01461", "PMC7075650", "26878082"]}, {"Citation": "Popp, F. D. (1969). Synthesis of potential antineoplastic agents. XX. Compounds related to the 3-o-nitrophenylhydrazone of isatin. Journal of Medicinal Chemistry, 12(1), 182\u2013184. 10.1021/jm00301a054", "ArticleIdList": ["10.1021/jm00301a054", "5763024"]}, {"Citation": "Rasul, A., Millimouno, F. M., Ali Eltayb, W., Ali, M., Li, J., & Li, X. (2013). Pinocembrin: A novel natural compound with versatile pharmacological and biological activities. BioMed Research International, 2013, 379850.", "ArticleIdList": ["PMC3747598", "23984355"]}, {"Citation": "Raugi, D. N., Smith, R. A., Gottlieb, G. S., & Group, U. (2016). Four amino acid changes in HIV-2 protease confer class-wide sensitivity to protease inhibitors. Journal of Virology, 90(2), 1062\u20131069. 10.1128/JVI.01772-15", "ArticleIdList": ["10.1128/JVI.01772-15", "PMC4702657", "26559830"]}, {"Citation": "Rozas, I. (1997). Atomic charges derived from different methods: A comparative study applied to SO2 heterocycles. International Journal of Quantum Chemistry, 62(5), 477\u2013487."}, {"Citation": "Scavone, C., Brusco, S., Bertini, M., Sportiello, L., Rafaniello, C., Zoccoli, A., Berrino, L., Racagni, G., Rossi, F., & Capuano, A. (2020). Current pharmacological treatments for COVID\u201019: What\u2019s next? British Journal of Pharmacology, 177(21), 4813\u20134824.", "ArticleIdList": ["PMC7264618", "32329520"]}, {"Citation": "Schelman, W. R., Liu, G., Wilding, G., Morris, T., Phung, D., & Dreicer, R. (2011). A phase I study of zibotentan (ZD4054) in patients with metastatic, castrate-resistant prostate cancer. Investigational New Drugs, 29(1), 118\u2013125. 10.1007/s10637-009-9318-5", "ArticleIdList": ["10.1007/s10637-009-9318-5", "PMC3008512", "19763400"]}, {"Citation": "Schmid, N., Eichenberger, A. P., Choutko, A., Riniker, S., Winger, M., Mark, A. E., & van Gunsteren, W. F. (2011). Definition and testing of the GROMOS force-field versions 54A7 and 54B7. European Biophysics Journal: EBJ, 40(7), 843\u2013856. 10.1007/s00249-011-0700-9", "ArticleIdList": ["10.1007/s00249-011-0700-9", "21533652"]}, {"Citation": "Schuttelkopf, A. W., & Van Aalten, D. M. F. (2004). PRODRG: A tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallographica Section D: Biological Crystallography, 60(8), 1355\u20131363.", "ArticleIdList": ["15272157"]}, {"Citation": "Selvam, P., Murgesh, N., Chandramohan, M., De Clercq, E., Keyaerts, E., Vijgen, L., Maes, P., Neyts, J., & Ranst, M. V. (2008). In vitro antiviral activity of some novel isatin derivatives against HCV and SARS-CoV viruses. Indian Journal of Pharmaceutical Sciences, 70(1), 91\u201394. 10.4103/0250-474X.40339", "ArticleIdList": ["10.4103/0250-474X.40339", "PMC2852069", "20390088"]}, {"Citation": "Serafim, R. A. M., de Oliveira, T. F., Loureiro, A. P. M., Krogh, R., Andricopulo, A. D., Dias, L. C., & Ferreira, E. I. (2017). Molecular modeling and structure\u2013activity relationships studies of bioisoster hybrids of N-acylhydrazone and furoxan groups on cruzain. Medicinal Chemistry Research, 26(4), 760\u2013769. 10.1007/s00044-016-1776-7", "ArticleIdList": ["10.1007/s00044-016-1776-7"]}, {"Citation": "Sheahan, T. P., Sims, A. C., Zhou, S., Graham, R. L., Pruijssers, A. J., Agostini, M. L., Leist, S. R., Sch\u00e4fer, A., Dinnon, K. H., Stevens, L. J., Chappell, J. D., Lu, X., Hughes, T. M., George, A. S., Hill, C. S., Montgomery, S. A., Brown, A. J., Bluemling, G. R., Natchus, M. G., \u2026 Baric, R. S. (2020). An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice. Science Translational Medicine, 12(541), eabb5883.", "ArticleIdList": ["PMC7164393", "32253226"]}, {"Citation": "Shiraki, K., & Daikoku, T. (2020). Favipiravir, an anti-influenza drug against life-threatening RNA virus infections. Pharmacology & Therapeutics, 107512.", "ArticleIdList": ["PMC7102570", "32097670"]}, {"Citation": "Sreekanth, K., & Jha, A. (2020). Microwave assisted synthesis and antimicrobial activity of novel pyrrolidine derivatives. Russian Journal of General Chemistry, 90(1), 129\u2013134. 10.1134/S107036322001020X", "ArticleIdList": ["10.1134/S107036322001020X"]}, {"Citation": "Tamokou, J-d-D., Tsemeugne, J., Fondjo, E. S., Sarkar, P., Kuiate, J.-R., Djintchui, A. N., Sondengam, B. L., & Bag, P. K. (2016). Antibacterial and cytotoxic activities and SAR of some azo compounds containing thiophene backbone. Pharmacologia, 7(4), 182\u2013192."}, {"Citation": "Teitz, Y., Ronen, D., Vansover, A., Stematsky, T., & Riggs, J. L. (1994). Inhibition of human immunodeficiency virus by N-methylisatin-beta 4':4'-diethylthiosemicarbazone and N-allylisatin-beta-4':4'-diallythiosemicarbazone. Antiviral Research, 24(4), 305\u2013314. 10.1016/0166-3542(94)90077-9", "ArticleIdList": ["10.1016/0166-3542(94)90077-9", "7993075"]}, {"Citation": "Tsuzuki, S., Uchimaru, T., Tanabe, K., & Yliniemela, A. (1996). Comparison of atomic charge distributions obtained from different procedures: Basis set and electron correlation effects. Journal of Molecular Structure: Theochem, 365(2\u20133), 81\u201388. 10.1016/0166-1280(96)04500-9", "ArticleIdList": ["10.1016/0166-1280(96)04500-9"]}, {"Citation": "Van Der Spoel, D., Lindahl, E., Hess, B., Groenhof, G., Mark, A. E., & Berendsen, H. J. C. (2005). GROMACS: Fast, flexible, and free. Journal of Computational Chemistry, 26(16), 1701\u20131718. 10.1002/jcc.20291", "ArticleIdList": ["10.1002/jcc.20291", "16211538"]}, {"Citation": "Varma, R. S., & Nobles, W. L. (1967). Synthesis and antiviral and antibacterial activity of certain N-dialkylaminomethylisatin beta-thiosemicarbazones. Journal of Medicinal Chemistry, 10(5), 972\u2013974. 10.1021/jm00317a061", "ArticleIdList": ["10.1021/jm00317a061", "4292737"]}, {"Citation": "Venkatarao, V., Kumar, L., Jha, A., & Sridhar, G. (2019). Synthesis and biological evaluation of chalcone fused quinoline derivatives as anticancer agents. Chemical Data Collections, 22, 100236. 10.1016/j.cdc.2019.100236", "ArticleIdList": ["10.1016/j.cdc.2019.100236"]}, {"Citation": "Vishnu Nayak, B., Ciftci-Yabanoglu, S., Singh Jadav, S., Jagrat, M., Sinha, B. N., Ucar, G., & Jayaprakash, V. (2013). Monoamine oxidase inhibitory activity of 3,5-biaryl-4,5-dihydro-1H-pyrazole-1-carboxylate derivatives. European Journal of Medicinal Chemistry, 69, 762\u2013767. 10.1016/j.ejmech.2013.09.010", "ArticleIdList": ["10.1016/j.ejmech.2013.09.010", "24099995"]}, {"Citation": "Wang, F., Chen, C., Tan, W., Yang, K., & Yang, H. (2016). Structure of main protease from human coronavirus NL63: Insights for wide spectrum anti-coronavirus drug design. Scientific Reports, 6, 22677. 10.1038/srep22677", "ArticleIdList": ["10.1038/srep22677", "PMC4780191", "26948040"]}, {"Citation": "Wang, J., Fang, X., Ge, L., Cao, F., Zhao, L., Wang, Z., & Xiao, W. (2018). Antitumor, antioxidant and anti-inflammatory activities of kaempferol and its corresponding glycosides and the enzymatic preparation of kaempferol. PLoS One, 13(5), e0197563. 10.1371/journal.pone.0197563", "ArticleIdList": ["10.1371/journal.pone.0197563", "PMC5957424", "29771951"]}, {"Citation": "Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W., & Xiao, G. (2020). Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in\u00a0vitro. Cell Research, 30(3), 269\u2013271. 10.1038/s41422-020-0282-0", "ArticleIdList": ["10.1038/s41422-020-0282-0", "PMC7054408", "32020029"]}, {"Citation": "Wu, C., Liu, Y., Yang, Y., Zhang, P., Zhong, W., Wang, Y., Wang, Q., Xu, Y., Li, M., Li, X., Zheng, M., Chen, L., & Li, H. (2020. a). Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharmaceutica Sinica. B, 10(5), 766\u2013788.", "ArticleIdList": ["PMC7102550", "32292689"]}, {"Citation": "Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., Yuan, M.-L., Zhang, Y.-L., Dai, F.-H., Liu, Y., Wang, Q.-M., Zheng, J.-J., Xu, L., Holmes, E. C., & Zhang, Y.-Z. (2020. b). A new coronavirus associated with human respiratory disease in China. Nature, 579(7798), 265\u2013269. 10.1038/s41586-020-2008-3", "ArticleIdList": ["10.1038/s41586-020-2008-3", "PMC7094943", "32015508"]}, {"Citation": "Xu, Z., Zhao, S.-J., & Liu, Y. (2019). 1, 2, 3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships. European Journal of Medicinal Chemistry, 183, 111700.", "ArticleIdList": ["31546197"]}, {"Citation": "Xu, J., Shi, P.-Y., Li, H., & Zhou, J. (2020. a). Broad spectrum antiviral agent niclosamide and its therapeutic potential. ACS Infectious Diseases, 6(5), 909\u2013915. 10.1021/acsinfecdis.0c00052", "ArticleIdList": ["10.1021/acsinfecdis.0c00052", "PMC7098069", "32125140"]}, {"Citation": "Xu, Z., Peng, C., Shi, Y., Zhu, Z., Mu, K., Wang, X., & Zhu, W. (2020. b). Nelfinavir was predicted to be a potential inhibitor of 2019-nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation. BioRxiv."}, {"Citation": "Xue, X., Yu, H., Yang, H., Xue, F., Wu, Z., Shen, W., Li, J., Zhou, Z., Ding, Y., Zhao, Q., Zhang, X. C., Liao, M., Bartlam, M., & Rao, Z. (2008). Structures of two coronavirus main proteases: Implications for substrate binding and antiviral drug design. Journal of Virology, 82(5), 2515\u20132527. 10.1128/JVI.02114-07", "ArticleIdList": ["10.1128/JVI.02114-07", "PMC2258912", "18094151"]}, {"Citation": "Yadagiri, B., Gurrala, S., Bantu, R., Nagarapu, L., Polepalli, S., Srujana, G., & Jain, N. (2015). Synthesis and evaluation of benzosuberone embedded with 1,3,4-oxadiazole, 1,3,4-thiadiazole and 1,2,4-triazole moieties as new potential anti proliferative agents. Bioorganic & Medicinal Chemistry Letters, 25(10), 2220\u20132224. 10.1016/j.bmcl.2015.03.032", "ArticleIdList": ["10.1016/j.bmcl.2015.03.032", "25827522"]}, {"Citation": "Yang, S., Chen, S.-J., Hsu, M.-F., Wu, J.-D., Tseng, C.-T K., Liu, Y.-F., Chen, H.-C., Kuo, C.-W., Wu, C.-S., Chang, L.-W., Chen, W.-C., Liao, S.-Y., Chang, T.-Y., Hung, H.-H., Shr, H.-L., Liu, C.-Y., Huang, Y.-A., Chang, L.-Y., Hsu, J.-C., \u2026 Hsu, M.-C. (2006). Synthesis, crystal structure, structure-activity relationships, and antiviral activity of a potent SARS coronavirus 3CL protease inhibitor. Journal of Medicinal Chemistry, 49(16), 4971\u20134980. 10.1021/jm0603926", "ArticleIdList": ["10.1021/jm0603926", "16884309"]}, {"Citation": "Zhang, H., Saravanan, K. M., Yang, Y., Hossain, M. T., Li, J., Ren, X., Pan, Y., & Wei, Y. (2020. a). Deep learning based drug screening for novel coronavirus 2019-nCov. Interdisciplinary Sciences, Computational Life Sciences, 12, 368\u2013376.", "ArticleIdList": ["PMC7266118", "32488835"]}, {"Citation": "Zhang, L., Lin, D., Kusov, Y., Nian, Y., Ma, Q., Wang, J., von Brunn, A., Leyssen, P., Lanko, K., Neyts, J., de Wilde, A., Snijder, E. J., Liu, H., & Hilgenfeld, R. (2020. b). \u03b1-Ketoamides as broad-spectrum inhibitors of coronavirus and enterovirus replication: Structure-based design, synthesis, and activity assessment. Journal of Medicinal Chemistry, 63(9), 4562\u20134578. 10.1021/acs.jmedchem.9b01828", "ArticleIdList": ["10.1021/acs.jmedchem.9b01828", "32045235"]}, {"Citation": "Zhang, L., Lin, D., Sun, X., Curth, U., Drosten, C., Sauerhering, L., Becker, S., Rox, K., & Hilgenfeld, R. (2020. c). Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors. Science, 368(6489), 409\u2013412. 10.1126/science.abb3405", "ArticleIdList": ["10.1126/science.abb3405", "PMC7164518", "32198291"]}, {"Citation": "Zhang, X.-M., Qiu, M., Sun, J., Zhang, Y.-B., Yang, Y.-S., Wang, X.-L., Tang, J.-F., & Zhu, H.-L. (2011). Synthesis, biological evaluation, and molecular docking studies of 1,3,4-oxadiazole derivatives possessing 1,4-benzodioxan moiety as potential anticancer agents. Bioorganic & Medicinal Chemistry, 19(21), 6518\u20136524.", "ArticleIdList": ["21962523"]}, {"Citation": "Zhou, L., Liu, Y., Zhang, W., Wei, P., Huang, C., Pei, J., Yuan, Y., & Lai, L. (2006). Isatin compounds as noncovalent SARS coronavirus 3C-like protease inhibitors. Journal of Medicinal Chemistry, 49(12), 3440\u20133443. 10.1021/jm0602357", "ArticleIdList": ["10.1021/jm0602357", "16759084"]}, {"Citation": "Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., Chen, H.-D., Chen, J., Luo, Y., Guo, H., Jiang, R.-D., Liu, M.-Q., Chen, Y., Shen, X.-R., Wang, X., \u2026 Shi, Z.-L. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579(7798), 270\u2013273. 10.1038/s41586-020-2012-7", "ArticleIdList": ["10.1038/s41586-020-2012-7", "PMC7095418", "32015507"]}]}], "History": [{"Year": "2020", "Month": "11", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "4", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "11", "Day": "17", "Hour": "8", "Minute": "39"}, {"Year": "2020", "Month": "11", "Day": "23"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33200681", "PMC7682386", "10.1080/07391102.2020.1845800"]}}]}